(Q39584211)

13 September 2017

title

Proton pump inhibitors reduce interferon-γ-induced neurotoxicity and STAT3 phosphorylation of human astrocytes (English)

1 reference

13 September 2017

0 references

0 references

1 reference

1 reference

1 reference

Sadayuki Hashioka

1

1 reference

13 September 2017

Andis Klegeris

series ordinal

2

1 reference

13 September 2017

Patrick L McGeer

series ordinal

3

1 reference

13 September 2017

publication date

28 February 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

59

1 reference

13 September 2017

issue

5

1 reference

13 September 2017

page(s)

833-840

1 reference

Differential regulation of STAT family members by glycogen synthase kinase-3

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Guide to the use of proton pump inhibitors in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high-performance liquid chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Proton pump inhibitor lansoprazole is a nuclear liver X receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Proton pump inhibitors: predisposers to Alzheimer disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Mechanisms underlying inflammation in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

IFNgamma signaling-does it mean JAK-STAT?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

STAT3 inhibitors attenuate interferon-γ-induced neurotoxicity and inflammatory molecule production by human astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Neuroglia in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Differential effects of protein tyrosine kinase inhibitors on interferon-gamma-induction of major histocompatibility complex class II and intercellular adhesion molecule-1 expression in human corneal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Modulation of human microglia and THP-1 cell toxicity by cytokines endogenous to the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Inhibition of cerebrospinal fluid formation by omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Inflammatory processes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Inflammatory processes in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Glial reactions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Protective effects of nicergoline against neuronal cell death induced by activated microglia and astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Rac1 contributes to maximal activation of STAT1 and STAT3 in IFN-gamma-stimulated rat astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

STAT3 revs up the powerhouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Astrocytes: biology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Lansoprazole, a Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis Factor-alpha and Interleukin-1beta Induced by Lipopolysaccharide and Helicobacter Pylori Bacterial Components in Human Monocytic Cells via Inhibition of Activation of Nuc

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

7 January 2021

Omeprazole: pharmacokinetics and metabolism in man.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

7 January 2021

Neuronal death in cytokine-activated primary human brain cell culture: role of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

7 January 2021

Intravenous omeprazole: effect on 24-hour intragastric pH in duodenal ulcer patients

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

7 January 2021

The inhibitory effects of H+ K+ ATPase inhibitors on human neutrophils in vitro: restoration by a K+ ionophore

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

7 January 2021

Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

7 January 2021

A new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21157

7 January 2021

Identifiers

DOI

10.1002/GLIA.21157

1 reference

13 September 2017

1 reference